title: Effect of intralipid on the phagocytic and microbicidal capacity of human monocytes in culture.
abstract: We studied the effect of Intralipid (IL) in monocyte cultures based on the ability of the cultures to phagocytose and kill Candida albicans and produce the oxidative burst. The IL was taken up by monocytes in cultures, and these cells phagocytosed more Candida organisms than did the control cells [85 +/- 2.2% in the IL treated (1%) compared to 68 +/- 2.3% after 1 h in the control]. The percentage of killing of Candida albicans, which had been taken up by the IL-treated monocytes measured after 2 h in culture (48.3 +/- 6.0%), was no different when compared to control (47.0 +/- 5.8%). Following ingestion of IL, there was an increase in basal H2O2 production, however, the presence of the IL in the cells had no effect on the expected increase in H2O2 production following stimulation with either phorbol myristate acetate (PMA) or zymosan particles. Compared to untreated cells, a significant increase in the number of monocytes with positive nitroblue tetrazolium staining was observed in monocytes that had ingested IL (when they were stimulated with either PMA or Candida microorganisms). Similar results were obtained in monocyte-derived macrophages (i.e., monocytes in monolayer cultures for 10 days). These findings suggest that the essential monocyte functions of phagocytosis, microbicidal activity, and ability to elicit an oxidative burst are not directly altered by the conventional use of IL in clinical practice.
authors.affiliation: Samuel Jared Kushnick Pediatric Immunology Laboratory, Chaim Sheba Medical Center, Tel-Aviv, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Padeh
authors.forename: R
authors.initials: R
authors.lastname: Shor
authors.forename: J H
authors.initials: JH
authors.lastname: Passwell
mesh_terms: D002176:Candida albicans / Q000187:drug effects*; D046508:Culture Techniques; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism; D009580:Nitroblue Tetrazolium / Q000378:metabolism; D010084:Oxidation-Reduction; D010587:Phagocytosis / Q000187:drug effects*
chemical_list: D005217:Fat Emulsions, Intravenous; D009580:Nitroblue Tetrazolium; D006861:Hydrogen Peroxide